Name (Synonyms) | Correlation | |
---|---|---|
drug915 | Zinc Wiki | 1.00 |
drug901 | Vitamin D Wiki | 0.58 |
drug900 | Vitamin C Wiki | 0.45 |
drug360 | Hydroxychloroquine Wiki | 0.13 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.12 |
D014777 | Virus Diseases NIH | 0.11 |
D007239 | Infection NIH | 0.08 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.07 |
D018352 | Coronavirus Infections NIH | 0.06 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The main objective of this study is to assess the efficacy of the combination hydroxychloroquine and Azithromycin (HCQ and AZ) in reducing the infection risk among health care professionals in direct contact with COVID-19 patients.
Description: Compare the proportion of participants who have RT-PCR confirmed infection with SARS-CoV-2 in both arms during the study period, measured by negative PCR test for SARS COV-2 virus
Measure: Effect of HCQ and AZ in preventing infection with COVID-19 among healthcare workers working with COVID-19 patients Time: 4 monthsDescription: Solicited and unsolicited adverse events in participants receiving HCQ+AZ during the study period, measured by the incidence of AEs in both arms. (The difference in type, number, and intensity)
Measure: Safety of HCQ and AZ Time: 4 monthsDescription: The proportion of participants who require oxygen therapy for any indication during the study period in both arms, measured by the requirement for O2 or not in both arms.
Measure: Oxygen requirement Time: 4 MonthsDescription: The proportion of participants who need ICU admission for any reason during the study period in both arms, measured by the incidence of ICU admission in both arms.
Measure: ICU admission Time: 4 MonthsDescription: The proportion of participants who die of any cause during the study period in both arms, measured by the incidence of death in both arms.
Measure: Mortality rate Time: 4 Months